Ovid Therapeutics Inc.OVIDNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank64
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-42.44M
↓ 12% vs avg
Percentile
P64
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-37.83M
Historical baseline
PeriodValueYoY Change
2025$-42.44M+31.4%
2024$-61.88M-4.4%
2023$-59.28M-6.7%
2022$-55.55M-144.7%
2021$124.21M+252.5%
2020$-81.43M-32.6%
2019$-61.41M-16.0%
2018$-52.93M+18.6%
2017$-65.01M-188.5%
2016$-22.54M-